Stockreport

Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026

Definium Therapeutics, Inc. - Common Shares  (DFTX) 
PDF NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company devel [Read more]